Filing Details
- Accession Number:
- 0001645627-17-000097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-24 15:16:21
- Reporting Period:
- 2017-07-19
- Filing Date:
- 2017-07-24
- Accepted Time:
- 2017-07-24 15:16:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-07-19 | 7,000 | $0.02 | 21,778,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,780,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,782,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,784,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,786,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,791,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 10,000 | $0.02 | 21,801,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,806,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,808,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,813,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,818,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,820,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,825,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,827,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,829,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,834,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,836,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,838,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,843,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,845,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,847,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,852,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,854,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,856,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,858,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,370 | $0.02 | 21,863,389 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,865,389 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 5,000 | $0.02 | 21,870,389 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-19 | 2,000 | $0.02 | 21,872,389 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-20 | 2,000 | $0.02 | 21,874,389 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |